Advertisement

Topics

Cytovia, Inc., Immune Pharma???s Oncology Subsidiary, Announces Publication Of Results Showing Anti-Metastatic Properties Of Its Lead Drug Ceplene And Filing Of A New Worldwide Patent

20:00 EDT 9 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Cytovia, Inc., Immune Pharma???s Oncology Subsidiary, Announces Publication Of Results Showing Anti-Metastatic Properties Of Its Lead Drug Ceplene And Filing Of A New Worldwide Patent

NEXT ARTICLE

More From BioPortfolio on "Cytovia, Inc., Immune Pharma???s Oncology Subsidiary, Announces Publication Of Results Showing Anti-Metastatic Properties Of Its Lead Drug Ceplene And Filing Of A New Worldwide Patent"

Quick Search
Advertisement